CDMOHUBCDMOHUB
Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    1. Home
    2. /CDMOs
    3. /Agno Pharmaceuticals
    Agno Pharmaceuticals logo

    Agno Pharmaceuticals

    CDMO
    United States
    https://agnopharma.com/

    Is this your company? Claim this profile

    Drug Substance
    Drug Product
    Regulatory, Tech Transfer & Support Services
    Chemistry, Manufacturing and Controls
    Analytical & Bioanalytical Services
    Advanced Modalities
    Qualification/Validation Services
    Company Overview

    About

    Agno Pharmaceuticals is a U.S.-headquartered global end-to-end CDMO providing comprehensive solutions from API development and intermediates through complex drug product formulation to cGMP manufacturing for both clinical trials and commercial production. The company supports both innovative and generic pharmaceutical sectors with capabilities in small molecule APIs, highly potent APIs (HPAPIs), sterile APIs, and drug products.

    Key Expertise

    Small molecule API manufacturing, HPAPIs, sterile APIs, drug product formulation, clinical and commercial cGMP manufacturing, regulatory starting materials, intermediates

    Therapeutic Areas

    Oncology
    CNS (Central Nervous System)
    Immunology
    Metabolic Disease
    Quick Facts
    HQ:United States
    Capabilities & Services

    Core Capabilities

    • Small Molecule API
    • Small Molecule Drug Product
    • Oral Solid Dose

    Dosage Forms

    Oral Solid Dose
    Sterile Injectable
    Lyophilized (Freeze-Dried)

    Containment Capabilities

    OEB 4 (1-10 µg/m³)
    OEB 5 (<1 µg/m³)

    Production Scales

    R&D / Pre-clinical
    Pilot Scale
    Phase I Clinical Trials
    Phase II
    Clinical
    Phase III Clinical Trials
    Commercial Scale

    Annual Capacity

    Small Batch / R&D (< 100 kg/year)
    Medium Clinical (100 - 1,000 kg/year)
    Commercial (1,000 - 10,000 kg/year)

    Markets Served

    North America
    Asia
    Manufacturing Facilities

    2 sites worldwide

    Agno Pharmaceuticals - China Facility

    China
    View on Map

    Agno Pharmaceuticals - United States Facility

    United States
    View on Map

    Site Capabilities

    3 capabilities
    Quality Control
    Stability Testing
    Method Development
    Clinical Trial Experience

    Involvement in 20 clinical trials

    Therapeutic Areas
    CNS/Neurology
    Hematology
    Immunology
    Metabolic/Endocrine
    Oncology
    Certifications

    FDA Registration

    U.S. Food and Drug Administration
    Request an Introduction

    Please log in to contact this provider.

    Key facts about Agno Pharmaceuticals

    • Agno Pharmaceuticals is headquartered in the United States.
    • Agno Pharmaceuticals has 2 manufacturing sites listed on CDMO Hub, in China and the United States.
    • Agno Pharmaceuticals's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.

    Find CDMOs like Agno Pharmaceuticals

    Directory pages this company appears in, each with the full list of matching manufacturers.

    CDMOs in United StatesCDMOs in North AmericaSmall Molecule API CDMOsSmall Molecule Drug Product CDMOsOral Solid Dose CDMOsOral Solid Dose CDMOsSterile Injectable CDMOsLyophilized (Freeze-Dried) CDMOsOEB 4 (1-10 µg/m³) CDMOs
    CDMOHUB

    Connecting biotech and pharma teams with contract manufacturing partners worldwide.

    Platform

    • Find CDMOs
    • CDMO Matchmaking
    • Expert Matchmaking
    • SmartRFI
      Members
    • Modality Guides
    • Supplier Maps
    • Join as Partner

    Company

    • Blog
    • Briefings
    • About Us
    • Contact

    Legal

    • Terms of Service
    • Privacy Policy

    © 2026 CDMOHUB. All rights reserved.

    CDMO Hub, Inc. Registered in Delaware, USA